发明名称 |
Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis |
摘要 |
The disclosure provides the use of GLP-1 receptor agonist compounds to treat pancreatitis (e.g., acute, chronic, hemorrhagic, necrotizing) in patients. The disclosure also provides the use of GLP-1 receptor agonist compounds to reduce elevated plasma amylase and/or lipase concentrations in patients. An exemplary GLP-1 receptor agonist compound is exenatide.
|
申请公布号 |
US8481490(B2) |
申请公布日期 |
2013.07.09 |
申请号 |
US201213567932 |
申请日期 |
2012.08.06 |
申请人 |
TATARKIEWICZ KRYSTYNA;PARKES DAVID G.;ROY DENIS;GEDULIN BRONISLAVA;AMYLIN PHARMACEUTICALS, LLC;ASTRAZENECA PHARMACEUTICALS LP |
发明人 |
TATARKIEWICZ KRYSTYNA;PARKES DAVID G.;ROY DENIS;GEDULIN BRONISLAVA |
分类号 |
A61K38/26;A61P3/10;A61P7/12;C07K14/605 |
主分类号 |
A61K38/26 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|